Combination therapy of immunostimulatory CVB3 and PD-L1 blockade enhanced anti-cancer efficacy of CVB3

被引：0
|
作者：
Miyamoto, Shohei [1 ]
Sagara, Miyako [2 ]
Ito, Shun [2 ]
Sakamoto, Akira [2 ]
Soda, Yasushi [2 ]
Akiyama, Tetsu [2 ]
Murahashi, Mutsunori [1 ]
Tani, Kenzaburo [2 ]
机构：
[1] Jikei Univ, Res Ctr Med Sci, Sch Med, Tokyo, Japan
[2] Univ Tokyo, Inst Quant Biosci, Tokyo, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-3083
引用
收藏
页码：1793 / 1793
页数：1
相关论文
共 50 条
  • [41] STAT3 Increases CVB3 Replication and Acute Pancreatitis and Myocarditis Pathology via Impeding Nuclear Translocation of STAT1 and Interferon-Stimulated Gene Expression
    Liang, Tianming
    Zhang, Zhipeng
    Bai, Zhenxin
    Xu, Le
    Xu, Wei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [42] Combination therapy with PD-1 or PD-L1 inhibitors for cancer
    Hayashi, Hidetoshi
    Nakagawa, Kazuhiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (05) : 818 - 830
  • [43] CVB3病毒VP1基因及其真核表达质粒的原子力显微镜图象
    赵铁强
    唐伟
    鲍英华
    国立秋
    赵清亮
    张飞虎
    董申
    中华实验和临床病毒学杂志, 2003, (04) : 89 - 89
  • [44] Combination therapy with PD-1 or PD-L1 inhibitors for cancer
    Hidetoshi Hayashi
    Kazuhiko Nakagawa
    International Journal of Clinical Oncology, 2020, 25 : 818 - 830
  • [45] Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
    Wu, Bogang
    Sun, Xiujie
    Gupta, Harshita B.
    Yuan, Bin
    Li, Jingwei
    Ge, Fei
    Chiang, Huai-Chin
    Zhang, Xiaowen
    Zhang, Chi
    Zhang, Deyi
    Yang, Jing
    Hu, Yanfen
    Curiel, Tyler J.
    Li, Rong
    ONCOIMMUNOLOGY, 2018, 7 (11):
  • [46] Systems pharmacology: a combination strategy for improving efficacy of PD-1/PD-L1 blockade
    Zheng, Chunli
    Xiao, Yue
    Chen, Chuang
    Zhu, Jinglin
    Yang, Ruijie
    Yan, Jiangna
    Huang, Ruifei
    Xiao, Wei
    Wang, Yonghua
    Huang, Chao
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (05)
  • [47] Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
    Sato, Hiro
    Okonogi, Noriyuki
    Nakano, Takashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (05) : 801 - 809
  • [48] Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
    Hiro Sato
    Noriyuki Okonogi
    Takashi Nakano
    International Journal of Clinical Oncology, 2020, 25 : 801 - 809
  • [49] Enhanced systemic antitumor efficacy of PD-1/PD-L1 blockade with immunological response induced by photodynamic therapy
    Sonokawa, Takumi
    Fujiwara, Yukio
    Pan, Cheng
    Komohara, Yoshihiro
    Usuda, Jitsuo
    THORACIC CANCER, 2024, 15 (18) : 1429 - 1436
  • [50] C家族趋化因子XCL1增强CVB3基因疫苗的抗病毒免疫应答及保护作用
    岳艳
    徐薇
    蒋正刚
    胡林昆
    李康
    熊思东
    现代免疫学, 2008, (02) : 91 - 95
12345